[The correction of the immune disorders in patients with chronic pyelonephritis and chronic kidney failure].
The trial entered 41 patients with chronic renal failure. Group I (15 patients) received conventional therapy involving infusion detoxication, antibiotics, immunostimulators, anabolic agents. 26 patients of group II in addition to standard therapeutic measures underwent plasmapheresis. The effect was assessed by immunological and renal function parameters. Group I patients have benefited from conventional treatment, but signs of immunodeficiency remained: B-lymphocyte, IgG and IgA levels were lowered and elevated, respectively. Patients of group II improved clinically, got rid of uremia and immunodeficiency.
Neĭmark
A I
AI
Iakovets
Ia V
IaV
D002908:Chronic Disease; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007154:Immune System Diseases / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D007668:Kidney / Q000002:abnormalities; D007676:Kidney Failure, Chronic / Q000150:complications / Q000276:immunology / Q000628:therapy*; D008297:Male; D010956:Plasmapheresis; D011470:Prostatic Hyperplasia / Q000150:complications / Q000276:immunology / Q000628:therapy; D011704:Pyelonephritis / Q000150:complications / Q000276:immunology / Q000628:therapy*; D014545:Urinary Calculi / Q000150:complications / Q000276:immunology / Q000628:therapy